http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005063969-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d7e470e09803bd6bf24b2fd176109dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6332931be897807c23005bfb5ad000ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02e698574bfe0acbbfc2e2d7c33dba13 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-515 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
| filingDate | 2004-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_958a9e23f40cab5c9dd8f99c247ce104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7dc3ca4baa91172fe5a7437544d3913 |
| publicationDate | 2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2005063969-A3 |
| titleOfInvention | Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and uses thereof |
| abstract | The invention relates to the fields of biology, genetics and medicine. The invention describes methods and compositions enabling (1) the identification of suppressor T cells or lymphocytes (Ts) or the precursors thereof (pTs) for diagnostic and therapeutical purposes and for carrying out genomic and proteomic studies, i.e. for the identification of new markers and/or therapeutical targets for said cells; (2) the production of of suppressor T cells or lymphocytes (Ts) or the precursors thereof (pTs) and/or the manipulations thereof in vivo or ex vivo for controlling various pathological conditions, including diseases associated with abnormal activity of effector and/or regulator lymphocytes. The invention relates to the preparation of said compositions based on Ts lymphocytes and pTS and to the use thereof in cell therapies. The compositions or cell populations based on the Ts lymphocytes and pTs obtained according to the invention are particularly suitable for the treatment of tumours, auto-immune diseases, allergies, graft-versus-host disease, graft versus infection effects (GVI) or graft-versus-leukemia effects (GVL), inflammatory diseases, type 1 diabetes, viral, bacterial or parasitic infections, for immune reconstruction or induction of tolerance in the event of transplantation of stem cells, tissue or organs in mammals. |
| priorityDate | 2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.